107 related articles for article (PubMed ID: 23276794)
1. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
Sehrawat A; Kim SH; Vogt A; Singh SV
Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
[TBL] [Abstract][Full Text] [Related]
2. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells.
Kim SH; Hahm ER; Singh SV
Mol Carcinog; 2023 Oct; 62(10):1449-1459. PubMed ID: 37265428
[TBL] [Abstract][Full Text] [Related]
4. Forkhead factor FOXQ1 promotes TGF-β1 expression and induces epithelial-mesenchymal transition.
Fan DM; Feng XS; Qi PW; Chen YW
Mol Cell Biochem; 2014 Dec; 397(1-2):179-86. PubMed ID: 25287361
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation.
Hahm ER; Kim SH; Pore SK; Mathan SV; Singh RP; Singh SV
Mol Carcinog; 2024 Feb; 63(2):301-313. PubMed ID: 37921547
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism.
Zielinska HA; Holly JMP; Bahl A; Perks CM
Cancer Lett; 2018 Apr; 419():187-202. PubMed ID: 29331414
[TBL] [Abstract][Full Text] [Related]
7. Carotenoids in Cancer Metastasis-Status Quo and Outlook.
Koklesova L; Liskova A; Samec M; Zhai K; Abotaleb M; Ashrafizadeh M; Brockmueller A; Shakibaei M; Biringer K; Bugos O; Najafi M; Golubnitschaja O; Büsselberg D; Kubatka P
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33321708
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer.
Škalamera D; Dahmer-Heath M; Stevenson AJ; Pinto C; Shah ET; Daignault SM; Said NA; Davis M; Haass NK; Williams ED; Hollier BG; Thompson EW; Gabrielli B; Gonda TJ
Oncotarget; 2016 Sep; 7(38):61000-61020. PubMed ID: 27876705
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation state of Ser
Markovsky E; de Stanchina E; Itzkowitz A; Haimovitz-Friedman A; Rotenberg SA
Cell Signal; 2018 Dec; 52():74-82. PubMed ID: 30176291
[TBL] [Abstract][Full Text] [Related]
10. Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.
Azimi I; Beilby H; Davis FM; Marcial DL; Kenny PA; Thompson EW; Roberts-Thomson SJ; Monteith GR
Mol Oncol; 2016 Jan; 10(1):166-78. PubMed ID: 26433470
[TBL] [Abstract][Full Text] [Related]
11. The influence of silver nanoparticles on the process of epithelial transition in the context of cancer metastases.
Matysiak-Kucharek M; Sawicki K; Kurzepa J; Wojtyła-Buciora P; Kapka-Skrzypczak L
Med Pr; 2023 Dec; 74(6):541-548. PubMed ID: 38160426
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells.
Vogiatzoglou AP; Spanou S; Sachini N; Drakos E; Nikolaou C; Makatounakis T; Kretsovali A; Papamatheakis J
Mol Oncol; 2023 Oct; 17(10):2090-2108. PubMed ID: 37518985
[TBL] [Abstract][Full Text] [Related]
13. Long-term cadmium exposure induces epithelial-mesenchymal transition in breast cancer cells by activating CYP1B1-mediated glutamine metabolic reprogramming in BT474 cells and MMTV-Erbb2 mice.
Li J; Gao P; Qin M; Wang J; Luo Y; Deng P; Hao R; Zhang L; He M; Chen C; Lu Y; Ma Q; Li M; Tan M; Wang L; Yue Y; Wang H; Tian L; Xie J; Chen M; Yu Z; Zhou Z; Pi H
Sci Total Environ; 2024 Mar; 918():170773. PubMed ID: 38336054
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Action of Benzyl Isothiocyanate and Sorafenib in a Nanoparticle Delivery System for Enhanced Triple-Negative Breast Cancer Treatment.
Wang Q; Cheng N; Wang W; Bao Y
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730647
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Evaluating the effect of Alantolactone on the expression of N-cadherin and Vimentin genes effective in epithelial-mesenchymal transition (EMT) in breast cancer cell line (MDA-MB-231): erratum.
Ann Med Surg (Lond); 2024 Jan; 86(1):630. PubMed ID: 38222727
[TBL] [Abstract][Full Text] [Related]
16. FOXQ1, a novel target of the Wnt pathway and a new marker for activation of Wnt signaling in solid tumors.
Christensen J; Bentz S; Sengstag T; Shastri VP; Anderle P
PLoS One; 2013; 8(3):e60051. PubMed ID: 23555880
[TBL] [Abstract][Full Text] [Related]
17. The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer.
Yuan H; Liang Y; Hu S; Chen J; You J; Jiang J; Luo M; Zeng M
Medicine (Baltimore); 2024 Apr; 103(15):e37709. PubMed ID: 38608123
[TBL] [Abstract][Full Text] [Related]
18. Reviewing the Prospective Pharmacological Potential of Isothiocyanates in Fight against Female-Specific Cancers.
Shoaib S; Khan FB; Alsharif MA; Malik MS; Ahmed SA; Jamous YF; Uddin S; Tan CS; Ardianto C; Tufail S; Ming LC; Yusuf N; Islam N
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190316
[TBL] [Abstract][Full Text] [Related]
19. Research Trend and Detailed Insights into the Molecular Mechanisms of Food Bioactive Compounds against Cancer: A Comprehensive Review with Special Emphasis on Probiotics.
Agrawal MY; Gaikwad S; Srivastava S; Srivastava SK
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428575
[TBL] [Abstract][Full Text] [Related]
20. Dietary phytochemicals/nutrients as promising protector of breast cancer development: a comprehensive analysis.
Samanta SK; Choudhury P; Sarma PP; Gogoi B; Gogoi N; Devi R
Pharmacol Rep; 2022 Aug; 74(4):583-601. PubMed ID: 35661126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
